Home / IBAC : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does IBAC make money? Does IBAC have pricing power? What's the Earnings Whisper? Will IBAC profit more as the business scales? What is IBAC's management track record? Is IBAC's current price justified?

IB Acquisition Corp. Common Stock

$10.88 +$0.38 (+3.62%)

NASDAQ · 11 Sep 2026 13:38 UTC

Previous Close

$10.92

Day Range

$10.88 - $10.88

Year Range

$10.19$11.45

Market Cap

54.49M

AVG Volume

2.95K

Trailing/Forward PE

-135.49/-

PEG ratio

Dividend Yield

Next Earnings Date

Primary Exchange

NASDAQ

Net Income (USD) · TTM

IBAC Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q3	-399.57K
26 Q2	986.21K
26 Q1	2.45M
25 Q4	3.42M
25 Q3	3.59M
25 Q2	3.88M
25 Q1	4.17M
24 Q4	3.18M
24 Q3	2.13M
24 Q2	1.01M

Operating Income (USD) · TTM

IBAC Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q3	-1.79M
26 Q2	-1.34M
26 Q1	-752.47K
25 Q4	-748.91K
25 Q3	-677.59K
25 Q2	-581.76K
25 Q1	-494.66K
24 Q4	-405.71K
24 Q3	-246.95K
24 Q2	-177.27K

EBITDA (USD) · TTM

IBAC EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q3	-534.54K
26 Q2	-82.32K
26 Q1	502.37K
25 Q4	505.93K
25 Q3	-677.59K
25 Q2	-581.76K
25 Q1	-494.66K
24 Q4	-405.71K
24 Q3	-246.95K
24 Q2	-170.62K

Cash Flows (USD) · TTM

IBAC Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q3	-1.85M
26 Q2	-1.52M
26 Q1	-1.99M
25 Q4	-1.32M
25 Q3	-1.31M
25 Q2	-1.23M
25 Q1	-586.76K
24 Q4	-315.36K
24 Q3	-339.55K
24 Q2	-285.76K

EPS (USD) · TTM

IBAC EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q3	-0.08
26 Q2	0.08
26 Q1	0.24
25 Q4	0.31
25 Q3	0.23
25 Q2	0.25
25 Q1	0.26
24 Q4	0.2
24 Q3	0.13
24 Q2	0.06

Expenses (USD) · TTM

IBAC Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q3	1.79M
26 Q2	1.34M
26 Q1	752.47K
25 Q4	748.91K
25 Q3	677.6K
25 Q2	581.77K
25 Q1	494.66K
24 Q4	405.71K
24 Q3	246.95K
24 Q2	170.62K

Shares Outstanding (USD) · TTM

IBAC Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q3	106.13M
26 Q2	114.02M
26 Q1	106.13M
25 Q4	106.13M
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0

PE Ratio

IBAC PE Ratio by quarter
Period	PE Ratio
Aug 26	62.98
Jul 26	62.92
Jul 26	62.8
Jul 26	62.8
Jul 26	62.8
Jul 26	62.74
Jun 26	62.8
Jun 26	62.8
Jun 26	62.57
Jun 26	62.86
May 26	62.45
May 26	62.8
May 26	62.63
May 26	25.37
May 26	25.35
Apr 26	25.3
Apr 26	25.21
Apr 26	25.18
Apr 26	25.11
Mar 26	24.97
Mar 26	25.25
Mar 26	25.14
Mar 26	25.11
Feb 26	25.07
Feb 26	25.04
Feb 26	24.95
Feb 26	17.74
Jan 26	17.73
Jan 26	17.66
Jan 26	17.68
Jan 26	17.68
Jan 26	17.64
Dec 25	45.9
Dec 25	45.9
Dec 25	45.9
Dec 25	45.9
Nov 25	46.12
Nov 25	45.81
Nov 25	45.9
Nov 25	45.85
Oct 25	45.81
Oct 25	45.9
Oct 25	46.03
Oct 25	45.85
Oct 25	46.12
Sep 25	46.34
Sep 25	46.42
Sep 25	46.47
Sep 25	46.38
Aug 25	46.29
Aug 25	46.16
Aug 25	46.03
Aug 25	31.09
Aug 25	31.06
Jul 25	31.03
Jul 25	31
Jul 25	30.97
Jul 25	31
Jun 25	31.03
Jun 25	30.94
Jun 25	30.91
Jun 25	30.88
May 25	30.94
May 25	30.88
May 25	30.82
May 25	39.13
May 25	39.13
Apr 25	39.13
Apr 25	39.05
Apr 25	39.09
Apr 25	39.01
Mar 25	38.86
Mar 25	38.9
Mar 25	39.01
Mar 25	38.9
Feb 25	38.75
Feb 25	38.56
Feb 25	38.56
Feb 25	50.74
Jan 25	50.79
Jan 25	50.69
Jan 25	50.49
Jan 25	50.34
Jan 25	50.24
Dec 24	50.19
Dec 24	74.73
Dec 24	74.8
Dec 24	74.66
Nov 24	74.21
Nov 24	74.29
Nov 24	74.51
Nov 24	74.44
Nov 24	74.51
Oct 24	74.14
Oct 24	74.07
Oct 24	73.92
Oct 24	74.07
Sep 24	73.92
Sep 24	73.99
Sep 24	73.7

Free Cash Flow Yield

IBAC Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-22.3%
Sep 26	-22.36%
Aug 26	-22.36%
Aug 26	-22.38%
Aug 26	-22.36%
Aug 26	-2.44%
Jul 26	-2.44%
Jul 26	-2.45%
Jul 26	-2.45%
Jul 26	-2.45%
Jul 26	-2.45%
Jun 26	-2.45%
Jun 26	-2.45%
Jun 26	-2.46%
Jun 26	-2.44%
May 26	-2.46%
May 26	-2.45%
May 26	-2.45%
May 26	-3.21%
May 26	-3.21%
Apr 26	-3.22%
Apr 26	-3.23%
Apr 26	-3.23%
Apr 26	-3.24%
Mar 26	-3.26%
Mar 26	-3.22%
Mar 26	-3.24%
Mar 26	-3.24%
Feb 26	-3.25%
Feb 26	-3.25%
Feb 26	-3.26%
Feb 26	-2.17%
Jan 26	-2.18%
Jan 26	-2.18%
Jan 26	-2.18%
Jan 26	-2.18%
Jan 26	-2.19%
Dec 25	-0.8%
Dec 25	-0.8%
Dec 25	-0.8%
Dec 25	-0.8%
Nov 25	-0.79%
Nov 25	-0.8%
Nov 25	-0.8%
Nov 25	-0.8%
Oct 25	-0.8%
Oct 25	-0.8%
Oct 25	-0.8%
Oct 25	-0.8%
Oct 25	-0.79%
Sep 25	-0.79%
Sep 25	-0.79%
Sep 25	-0.79%
Sep 25	-0.79%
Aug 25	-0.79%
Aug 25	-0.79%
Aug 25	-0.8%
Aug 25	-1.02%
Aug 25	-1.02%
Jul 25	-1.02%
Jul 25	-1.02%
Jul 25	-1.02%
Jul 25	-1.02%
Jun 25	-1.02%
Jun 25	-1.02%
Jun 25	-1.02%
Jun 25	-1.02%
May 25	-1.02%
May 25	-1.02%
May 25	-1.03%
May 25	-0.36%
May 25	-0.36%
Apr 25	-0.36%
Apr 25	-0.36%
Apr 25	-0.36%
Apr 25	-0.36%
Mar 25	-0.36%
Mar 25	-0.36%
Mar 25	-0.36%
Mar 25	-0.36%
Feb 25	-0.36%
Feb 25	-0.36%
Feb 25	-0.36%
Feb 25	-0.2%
Jan 25	-0.2%
Jan 25	-0.2%
Jan 25	-0.2%
Jan 25	-0.2%
Jan 25	-0.2%
Dec 24	-0.2%
Dec 24	-0.21%
Dec 24	-0.21%
Dec 24	-0.21%
Nov 24	-0.21%
Nov 24	-0.21%
Nov 24	-0.21%
Nov 24	-0.21%
Nov 24	-0.21%
Oct 24	-0.21%
Oct 24	-0.21%

EV/EBITDA

IBAC EV/EBITDA by quarter
Period	EV/EBITDA
May 26	123.41
May 26	123.3
Apr 26	123.07
Apr 26	122.61
Apr 26	122.5
Apr 26	122.15
Mar 26	121.47
Mar 26	122.84
Mar 26	122.27
Mar 26	122.15
Feb 26	121.93
Feb 26	121.81
Feb 26	121.35
Feb 26	118.96
Jan 26	118.85
Jan 26	118.39
Jan 26	118.51
Jan 26	118.51
Jan 26	118.28

Price to Book

IBAC Price to Book by quarter
Period	Price to Book
Sep 26	1.37
Sep 26	1.36
Aug 26	1.36
Aug 26	1.36
Aug 26	1.36
Aug 26	9.36
Jul 26	9.35
Jul 26	9.33
Jul 26	9.33
Jul 26	9.33
Jul 26	9.32
Jun 26	9.33
Jun 26	9.33
Jun 26	9.3
Jun 26	9.34
May 26	9.28
May 26	9.33
May 26	9.3
May 26	4.08
May 26	4.07
Apr 26	4.07
Apr 26	4.05
Apr 26	4.05
Apr 26	4.04
Mar 26	4.01
Mar 26	4.06
Mar 26	4.04
Mar 26	4.04
Feb 26	4.03
Feb 26	4.03
Feb 26	4.01
Feb 26	3.96
Jan 26	3.96
Jan 26	3.94
Jan 26	3.95
Jan 26	3.95
Jan 26	3.94
Dec 25	1.35
Dec 25	1.35
Dec 25	1.35
Dec 25	1.35
Nov 25	1.36
Nov 25	1.35
Nov 25	1.35
Nov 25	1.35
Oct 25	1.35
Oct 25	1.35
Oct 25	1.36
Oct 25	1.35
Oct 25	1.36
Sep 25	1.37
Sep 25	1.37
Sep 25	1.37
Sep 25	1.37
Aug 25	1.36
Aug 25	1.36
Aug 25	1.36
Aug 25	1
Aug 25	1
Jul 25	1
Jul 25	1
Jul 25	0.99
Jul 25	1
Jun 25	1
Jun 25	0.99
Jun 25	0.99
Jun 25	0.99
May 25	0.99
May 25	0.99
May 25	0.99
May 25	1.36
May 25	1.36
Apr 25	1.36
Apr 25	1.36
Apr 25	1.36
Apr 25	1.36
Mar 25	1.35
Mar 25	1.35
Mar 25	1.36
Mar 25	1.35
Feb 25	1.35
Feb 25	1.34
Feb 25	1.34
Feb 25	1.35
Jan 25	1.35
Jan 25	1.35
Jan 25	1.35
Jan 25	1.34
Jan 25	1.34
Dec 24	1.34
Dec 24	1.35
Dec 24	1.35
Dec 24	1.35
Nov 24	1.34
Nov 24	1.34
Nov 24	1.35
Nov 24	1.34
Nov 24	1.35
Oct 24	1.34
Oct 24	1.34

No video analysis for this stock yet. Request one from our team.

News: IBAC

defenseworld.net · 31 Aug 2026

Contrasting Charles River Laboratories International (NYSE:CRL) and IB Acquisition (NASDAQ:IBAC)

Charles River Laboratories International (NYSE: CRL - Get Free Report) and IB Acquisition (NASDAQ: IBAC - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership. Earnings and Valuation This table compares

AI Analysis

IB Acquisition Corp. Common Stock

Video analysis: IBAC

News: IBAC

Contrasting Charles River Laboratories International (NYSE:CRL) and IB Acquisition (NASDAQ:IBAC)

Similar companies